+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Modafinil Tablets Market - Global Forecast 2026-2032- Product Image
Modafinil Tablets Market - Global Forecast 2026-2032- Product Image
Sale

Modafinil Tablets Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6140222
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Modafinil Tablets Market is projected to reach USD 1.07 Billion in 2026. It is expected to continue growing at a CAGR of 7.71%, reaching USD 1.68 Billion by 2032.

Modafinil Tablets: Executive Summary and Market Context

Modafinil tablets are prescription medicines primarily associated with the management of excessive sleepiness linked to narcolepsy, obstructive sleep apnea, and shift-work sleep disorder, subject to jurisdiction-specific approvals. The market is shaped by clinical guidelines, controlled-substance rules, prescription access, pharmacovigilance obligations, and the need to distinguish approved therapeutic use from nonmedical cognitive-enhancement demand. Key strategic considerations include evidence quality, patient selection, adherence, formulation quality, and responsible communication of risks and benefits.

Regulatory and Care-Delivery Shifts Reshaping Modafinil Tablets

The landscape is being transformed by tighter scrutiny of controlled medicines, stronger expectations for post-market safety monitoring, and greater emphasis on diagnosis-led treatment pathways. Digital consultations and electronic prescribing can improve access where legally permitted, while also increasing the importance of identity verification, prescription validation, and safeguards against diversion. Generic competition and pharmacy-channel evolution place additional pressure on quality consistency, supply reliability, patient education, and differentiated clinical support.

Artificial Intelligence Strengthens Safety, Adherence, and Evidence Generation

Artificial intelligence can support modafinil tablet care by identifying patterns in sleep-related symptoms, flagging potential drug interactions, prioritizing pharmacovigilance cases, and helping clinicians monitor adherence. Its use should remain supervised and transparent: algorithms cannot replace diagnostic assessment, prescribing judgment, or evaluation of contraindications such as cardiovascular, psychiatric, or hypersensitivity risks. Leaders should validate models across relevant populations, protect patient data, document decision pathways, and monitor for bias and inappropriate use, including attempts to obtain medicines for nonmedical purposes.

Regional Insights: Regulation and Access Differ Across Six Operating Environments

North America is characterized by mature prescription systems, established sleep-medicine services, and strong controlled-substance oversight. Europe emphasizes harmonized safety expectations alongside national reimbursement and prescribing rules. Asia-Pacific combines advanced healthcare systems with substantial variation in regulatory access and diagnostic capacity. Latin America presents differing pharmacy controls, affordability conditions, and specialist availability. The Middle East is influenced by import procedures, centralized procurement in some jurisdictions, and uneven specialist coverage. Africa requires particular attention to diagnostic access, supply continuity, counterfeit-medicine prevention, and appropriate prescribing education.

Group Insights: Economic and Security Blocs Create Distinct Compliance Priorities

ASEAN markets require country-by-country assessment because medicine registration, controlled-substance classification, and distribution practices differ across members. BRICS countries reflect diverse healthcare infrastructures, domestic manufacturing capabilities, and enforcement environments, making local regulatory expertise essential. The European Union combines shared pharmacovigilance principles with national decisions on reimbursement and dispensing. G7 markets generally maintain extensive clinical evidence and safety-monitoring expectations. GCC markets often involve centralized procurement and import controls, while NATO membership should not be treated as a single pharmaceutical regulatory system; national rules remain decisive.

Country Insights: Local Approval, Prescribing, and Supply Rules Determine Execution

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States have comparatively developed regulatory and clinical infrastructures, but prescribing classifications, reimbursement, and dispensing requirements still differ. Brazil, Mexico, India, China, and Russia require careful review of local registration, controlled-medicine rules, distribution channels, and enforcement practices. Across all listed countries, sustainable execution depends on authorized supply, clinician education, counterfeit detection, adverse-event reporting, and clear separation between approved indications and nonmedical use. Country plans should be built from current official requirements rather than assumptions based on regional or political-group membership.

Practical Priorities for Leaders in Modafinil Tablet Programs

Industry leaders should establish a compliance-by-design operating model covering registration, controlled-substance obligations, prescription verification, supply-chain traceability, and adverse-event reporting. They should align evidence generation with recognized sleep-disorder needs, strengthen clinician and patient education, and use plain-language materials addressing interactions, psychiatric and cardiovascular considerations, hypersensitivity, and appropriate discontinuation discussions. Digital channels should include safeguards against diversion and misleading claims. Finally, organizations should monitor product quality, access barriers, diagnostic delays, and real-world safety outcomes through measurable governance dashboards.

Research Methodology: Evidence-Led, Jurisdiction-Specific Assessment

This executive summary uses a structured qualitative approach grounded in established clinical, regulatory, and pharmaceutical-safety principles. The assessment considers approved therapeutic contexts, prescribing and dispensing controls, pharmacovigilance, healthcare access, digital-care implications, supply-chain integrity, and responsible artificial-intelligence deployment. Regional, group, and country observations are framed as areas requiring jurisdiction-specific verification; they do not assume uniform rules within any geography. No market estimates, market sizing, market shares, forecasts, or company-specific claims are used.

Conclusion: Responsible Access and Evidence Quality Define Long-Term Resilience

The modafinil tablets landscape is governed less by product availability alone than by the quality of diagnosis, regulatory compliance, patient monitoring, and supply-chain trust. Regional and national differences make localized execution essential, while artificial intelligence offers value only when deployed with clinical oversight, privacy protection, and bias controls. Leaders that prioritize approved use, reliable product quality, transparent safety communication, and accountable distribution will be better positioned to support appropriate treatment and maintain confidence among clinicians, patients, regulators, and health systems.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Modafinil Tablets Market, by Product Type
7.1. Introduction
7.2. Branded
7.3. Generic
8. Modafinil Tablets Market, by Dosage Strength
8.1. Introduction
8.2. 100 Mg
8.3. 200 Mg
9. Modafinil Tablets Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Modafinil Tablets Market, by Application
10.1. Introduction
10.2. Cognitive Enhancement
10.2.1. Professional Use
10.2.2. Student Use
10.3. Sleep Disorder Treatment
10.3.1. Narcolepsy
10.3.2. Obstructive Sleep Apnea
10.3.3. Shift Work Sleep Disorder
11. Modafinil Tablets Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Modafinil Tablets Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Modafinil Tablets Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Modafinil Tablets Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alembic Pharmaceuticals Ltd.
16.2. Apotex Inc.
16.3. Aurobindo Pharma Ltd.
16.4. Cephalon Inc.
16.5. Cipla Health Pvt. Ltd.
16.6. Cipla Limited
16.7. Dr. Reddy’s Laboratories Ltd.
16.8. FDC Limited
16.9. Glenmark Pharmaceuticals Ltd.
16.10. HAB Pharmaceuticals & Research Ltd.
16.11. Hetero Healthcare Ltd.
16.12. Intas Pharmaceuticals Ltd.
16.13. Lupin Limited
16.14. Macleods Pharmaceuticals Ltd.
16.15. MSN Laboratories Ltd.
16.16. Orbion Pharmaceuticals, Inc.
16.17. Reddy’s Laboratories Limited
16.18. Sandoz International GmbH
16.19. Sun Pharmaceutical Industries Ltd.
16.20. Sunrise Pharmaceutical Pvt. Ltd.
16.21. Teva Pharmaceutical Industries Ltd.
16.22. Torrent Pharmaceuticals Ltd.
16.23. Viatris Inc.
16.24. Wockhardt Ltd.
16.25. Zydus Lifesciences Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Modafinil Tablets Market, Years Considered for the Study
FIGURE 2. Global Modafinil Tablets Market, Research Design
FIGURE 3. Global Modafinil Tablets Market, Research Framework
FIGURE 4. Global Modafinil Tablets Market, Data Triangulation
FIGURE 5. Global Modafinil Tablets Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Modafinil Tablets Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Modafinil Tablets Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Modafinil Tablets Market Size, by Dosage Strength, 2025 vs 2032 (%)
FIGURE 9. Global Modafinil Tablets Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Modafinil Tablets Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Modafinil Tablets Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Modafinil Tablets Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Modafinil Tablets Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Modafinil Tablets Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Modafinil Tablets Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Modafinil Tablets Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Modafinil Tablets Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Modafinil Tablets Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Modafinil Tablets Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Modafinil Tablets Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Modafinil Tablets Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Modafinil Tablets Market Segmentation & Coverage
TABLE 2. Global Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 3. Global Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Branded Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Branded Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Branded Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 11. Global 100 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global 100 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global 100 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global 200 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global 200 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global 200 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 18. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 19. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 20. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 21. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 28. Global Cognitive Enhancement Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Cognitive Enhancement Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Cognitive Enhancement Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Professional Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Professional Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Professional Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Student Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Student Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Student Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Sleep Disorder Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Sleep Disorder Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Sleep Disorder Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Narcolepsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Narcolepsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Narcolepsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Obstructive Sleep Apnea Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Obstructive Sleep Apnea Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Obstructive Sleep Apnea Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Shift Work Sleep Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Shift Work Sleep Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Shift Work Sleep Disorder Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 50. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Modafinil Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Modafinil Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. North America Modafinil Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. North America Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 70. North America Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 71. North America Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. North America Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. North America Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 74. North America Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 75. North America Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. Latin America Modafinil Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Latin America Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 78. Latin America Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 79. Latin America Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Latin America Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Latin America Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 82. Latin America Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 83. Latin America Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Europe Modafinil Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Europe Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 86. Europe Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 87. Europe Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 88. Europe Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Europe Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 90. Europe Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 91. Europe Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Middle East Modafinil Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Middle East Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 94. Middle East Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 95. Middle East Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. Middle East Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Middle East Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 98. Middle East Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 99. Middle East Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Africa Modafinil Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Africa Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. Africa Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 103. Africa Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 104. Africa Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Africa Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 106. Africa Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 107. Africa Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Global Modafinil Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. ASEAN Modafinil Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. ASEAN Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 112. ASEAN Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 113. ASEAN Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. ASEAN Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 115. ASEAN Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 116. ASEAN Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. GCC Modafinil Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. GCC Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. GCC Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 120. GCC Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. GCC Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. GCC Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 123. GCC Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 124. GCC Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. European Union Modafinil Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. European Union Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. European Union Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 128. European Union Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. European Union Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. European Union Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 131. European Union Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 132. European Union Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. BRICS Modafinil Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. BRICS Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. BRICS Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 136. BRICS Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. BRICS Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. BRICS Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 139. BRICS Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 140. BRICS Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. G7 Modafinil Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. G7 Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. G7 Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 144. G7 Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. G7 Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. G7 Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 147. G7 Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 148. G7 Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. NATO Modafinil Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. NATO Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. NATO Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 152. NATO Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. NATO Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. NATO Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 155. NATO Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 156. NATO Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Global Modafinil Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. United States Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 159. United States Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. United States Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 161. United States Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. United States Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. United States Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 164. United States Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 165. United States Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Canada Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 167. Canada Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. Canada Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 169. Canada Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. Canada Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. Canada Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 172. Canada Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 173. Canada Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Mexico Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 175. Mexico Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. Mexico Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 177. Mexico Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. Mexico Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Mexico Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 180. Mexico Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 181. Mexico Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Brazil Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 183. Brazil Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. Brazil Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 185. Brazil Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. Brazil Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Brazil Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 188. Brazil Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 189. Brazil Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. United Kingdom Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 191. United Kingdom Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. United Kingdom Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 193. United Kingdom Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. United Kingdom Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. United Kingdom Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 196. United Kingdom Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 197. United Kingdom Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. Germany Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 199. Germany Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. Germany Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 201. Germany Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. Germany Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. Germany Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 204. Germany Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 205. Germany Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. France Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 207. France Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. France Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 209. France Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. France Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. France Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 212. France Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 213. France Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Russia Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 215. Russia Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. Russia Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 217. Russia Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. Russia Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. Russia Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 220. Russia Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 221. Russia Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Italy Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 223. Italy Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. Italy Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 225. Italy Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. Italy Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Italy Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 228. Italy Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 229. Italy Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Spain Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 231. Spain Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Spain Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 233. Spain Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. Spain Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. Spain Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 236. Spain Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 237. Spain Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. China Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 239. China Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. China Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 241. China Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. China Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. China Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 244. China Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 245. China Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. India Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 247. India Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. India Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 249. India Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 250. India Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. India Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 252. India Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 253. India Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Japan Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 255. Japan Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. Japan Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 257. Japan Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 258. Japan Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Japan Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 260. Japan Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 261. Japan Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Australia Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 263. Australia Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. Australia Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 265. Australia Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 266. Australia Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. Australia Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 268. Australia Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 269. Australia Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. South Korea Modafinil Tablets Market Size, 2017-2032 (USD Million)
TABLE 271. South Korea Modafinil Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. South Korea Modafinil Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 273. South Korea Modafinil Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 274. South Korea Modafinil Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. South Korea Modafinil Tablets Market Size, by Cognitive Enhancement, 2017-2032 (USD Million)
TABLE 276. South Korea Modafinil Tablets Market Size, by Sleep Disorder Treatment, 2017-2032 (USD Million)
TABLE 277. South Korea Modafinil Tablets Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Global Modafinil Tablets Market Share, by Key Player, 2025
TABLE 279. Global Modafinil Tablets Market, Key Experts

Companies Mentioned

  • Alembic Pharmaceuticals Ltd.
  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Cephalon Inc.
  • Cipla Health Pvt. Ltd.
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • FDC Limited
  • Glenmark Pharmaceuticals Ltd.
  • HAB Pharmaceuticals & Research Ltd.
  • Hetero Healthcare Ltd.
  • Intas Pharmaceuticals Ltd.
  • Lupin Limited
  • Macleods Pharmaceuticals Ltd.
  • MSN Laboratories Ltd.
  • Orbion Pharmaceuticals, Inc.
  • Reddy’s Laboratories Limited
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Sunrise Pharmaceutical Pvt. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.
  • Wockhardt Ltd.
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Modafinil Oral Drugs Market - Global Forecast 2026-2032 - Product Image

Modafinil Oral Drugs Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Modafinil (CAS 68693-11-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Modafinil (CAS 68693-11-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Fast Melt Tablets Market Report 2026 - Product Image

Fast Melt Tablets Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Anshen Bunao Tablets Market - Global Forecast 2026-2032 - Product Image

Anshen Bunao Tablets Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Detachable Tablets - Global Strategic Business Report - Product Image

Detachable Tablets - Global Strategic Business Report

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.